Biomerica Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q1 Fiscal 2027 Earnings Release | 15 Oct 2026 |
Monitoring Framework
Key Performance Indicators
inFoods IBS Test Medicare Reimbursement Rate Annually30,000.0%
Quarterly Net Sales Quarterly990KTarget: Growth above 1.5M
CDMO Initial Contract Development Target Fee Annually1.8M
Watch Items
- Medicare Administrative Contractor (MAC) Coverage DeterminationsTrigger: Individual claim review approvals or local coverage determinations (LCDs) issuedAction: Monitor MAC updates and laboratory partner billing submissions to ensure scalable reimbursement.
- CDMO Statement of Work ExecutionTrigger: Execution of subsequent Statements of Work under the Master Services AgreementAction: Track milestone achievements and revenue recognition under the $1.75M CDMO agreement.
- Cash Burn and Liquidity PositionTrigger: Cash balance falling below $1.5 millionAction: Evaluate utilization of the existing shelf registration / ATM facility to support working capital.
Research as of 20 Jun 2026